세계의 바디 컨투어링 치료 시장 : 제품별, 유형별, 용도별, 최종 사용자별 - 예측(-2029년)

The global body contouring treatments market is expected to reach USD 2.58 billion by 2029 from USD 1.46 billion in 2024, at a CAGR of 10.0% from 2024 to 2029. Increase in acceptance of aesthetic procedures, coupled with personalized and flexible financing plans has increased the demand for these products. Growing interest in anti-aging procedures are more prevalent in aging population. Body contouring procedures helps to reshape and improvesconfidence. Moreover,increased benefits of minimally invasive and non-invasive body contouring procedures have driven demand for body contouring treatments market.

"The non-invasive technologies segment of technology segment held the largest share of the market in 2023"

The body contouring treatments market is segmented based on technology into invasive technologies and non-invasive technologies. The non-invasive technologies accounted for a major share in 2023. Increase in technological innovations, rise in advertisement, and the rising adoption of devices due to less incisions is anticipated to fuel the growth of the segment. Treatments for non-invasive body contouring that involve radiofrequency, ultrasound, cryolipolysis (freezing fat), and laser-based techniques have significantly improved in tems of safety and effectiveness. These technologies have a wide range of benefits, which contribute to the non-invasive treatment popularity among individuals.

"The non-surgical fat reduction segment of application segment held the largest share of the market in 2023"

The body contouring treatments market can be segmented based on application into abdominoplasty, liposuction, non-invasive fat reduction, cellulite treatment, and other applications. Increasing number of beauty centers and rising adoption mainly due to improved accuracy and better outcomes drives the market. The non-surgical fat reduction treatments are gaining popularity across all patient types and ages. Hence, broader acceptance for treatment procedures due to innovative technologies supports the surge in demand that further drives the growth for the non-surgical fat reduction segment.

"The female patients segment for patient type segment to hold the largest market share in 2023".

Based on patient type , the body contouring treatments market is segmented into female patients and male patients. Female patients is the major segment, accounting for the largest body contouring treatments market share in 2023. The increase in awareness about non-invasive body contouring procedures, rise in post-pregnancy body reconstruction procedures, increase in influencer endorsements, and social media promotion supports the growth of the segment.

"The aesthetic clinics segment for the end user segment is projected to register a significant CAGR during the forecast period."

The body contouring treatments market is segmented by end-users into hospitals, aesthetic clinics, and medical spas & beauty centers. The hospitals accounted for a major end-user market share in 2023. The increase in spending on body shaping procedures and rise in medical tourism, and rising disposable income per capita is anticipated to propel the segment growth. Furthermore, rising adoption of new and improved devices in the hopsitals is expected to support the growth of this segment.

"The market in the Asia Pacific region is expected to witness the highest growth during the forecast period."

The north america region accounted for major share in 2023. Asia pacific region to grow at the highest CAGR in body contouring treatments market. Healthcare infrastructure and service investments, especially in the emerging economies, are fostering the development of medical aesthetics, which leads to growing demand for body contouring. In this regard, market leaders have increased their efforts to strengthen their presence in the Asia Pacific market to meet the ever-growing requirement for body contouring treatment. The availability and accessibility of the service in this market have also been enhanced by the increasing presence of aesthetic clinics, particularly in the APAC region.

A breakdown of the primary participants referred to for this report is provided below:

• By Company Type: Tier 1-30%, Tier 2-42%, and Tier 3- 28%
• By Designation: Director-level-10%, C-level-14%, and Others-76%
• By Region: North America-40%, Europe-30%, Asia Pacific-22%, Latin America-6%, and RoW- 10%

The prominent players in the body contouring treatments market are as AbbVie Inc. (US), InMode Ltd. (Israel), Bausch Health Companies Inc. (Canada), Cynosure Lutronic (US), Venus Concept (Canada), EL.EN.S.P.A (Italy), Sisram Medical Ltd. (Israel), BTL Industries(UK), Sharplight Technologies Inc. (Canada), Sciton Inc. (US), Candela Corporation (US), Fotona (Solvenia )

The study includes as in-depth competitive analysis of these key players in the authentication and brand protection market, with their company profiles recent developments,and key market stratergies

Research Coverage

This report studies the body contouring treatments market based on technology, application, patient type, end user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will help market leaders and new entrants with information on the closest approximations of the revenue numbers for the overall body contouring treatments market and the subsegments. It will also help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.

This report provides insights on the following pointers:

• Analysis of key drivers (Growing adoption for minimally invasive and non-invasive body contouring procedure, increasing demand for aesthetic treatments among men, rising adoption of new and innovative body contouring technologies , broad acceptance of aesthetic procedure and growing attention on appearance and body image), restraints (high cost of treatment and inadequate reimbursement policies), opportunities (growth potential in emerging economies), and challenges (social and cultural barrriers in emerging economies, stringent regulatory compliance and safety standards) influencing the growth of the body contouring treatments market
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the body contouring treatments market
• Market Development: Comprehensive information about lucrative markets-the report analyses the body contouring treatments market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the body contouring treatments market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players, such as AbbVie Inc. (US), Inmode Ltd. (Israel), Bausch Health Companies Inc. (Canada), Cynosure Lutronic (US), Sisram Medical Ltd (Israel)

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 INCLUSIONS AND EXCLUSIONS
• 1.4 STUDY SCOPE
  • 1.4.1 MARKETS COVERED
  • 1.4.2 YEARS CONSIDERED
  • 1.4.3 CURRENCY CONSIDERED
• 1.5 STAKEHOLDERS
• 1.6 IMPACT OF AI/GEN AI

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key sources for secondary research
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key primary sources
    • 2.1.2.2 Key industry insights
    • 2.1.2.3 Breakdown of primary interviews
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 BOTTOM-UP APPROACH
    • 2.2.1.1 Company revenue estimation approach
    • 2.2.1.2 Customer-based market estimation
    • 2.2.1.3 Growth forecast approach
    • 2.2.1.4 CAGR projections
• 2.3 DATA TRIANGULATION
• 2.4 MARKET SHARE ANALYSIS
• 2.5 RESEARCH ASSUMPTIONS
  • 2.5.1 PARAMETRIC ASSUMPTIONS
  • 2.5.2 GROWTH RATE ASSUMPTIONS
• 2.6 RESEARCH LIMITATIONS
• 2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 BODY CONTOURING TREATMENTS MARKET OVERVIEW
• 4.2 NORTH AMERICA: BODY CONTOURING TREATMENTS MARKET, BY TECHNOLOGY
• 4.3 ASIA PACIFIC: BODY CONTOURING TREATMENTS MARKET, BY END USER
• 4.4 EUROPE: BODY CONTOURING TREATMENTS MARKET, BY APPLICATION
• 4.5 GEOGRAPHIC SNAPSHOT OF BODY CONTOURING TREATMENTS MARKET

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Growing adoption of minimally invasive and non-invasive body contouring procedures
    • 5.2.1.2 Increasing demand for aesthetic treatments among men
    • 5.2.1.3 Rising adoption of new and innovative body contouring technologies
    • 5.2.1.4 Widespread social media influence and cultural changes
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 High cost of treatment and inadequate reimbursement policies
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Growth potential in emerging economies
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Social and cultural barriers
    • 5.2.4.2 Stringent regulatory compliance and safety standards
• 5.3 VALUE CHAIN ANALYSIS
  • 5.3.1 RESEARCH & PRODUCT DEVELOPMENT
  • 5.3.2 RAW MATERIAL PROCUREMENT AND MANUFACTURING
  • 5.3.3 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES
• 5.4 SUPPLY CHAIN ANALYSIS
  • 5.4.1 MANUFACTURERS
    • 5.4.1.1 Prominent companies
    • 5.4.1.2 Small and medium-sized enterprises
  • 5.4.2 END USERS
• 5.5 ECOSYSTEM ANALYSIS
• 5.6 REGULATORY ANALYSIS
  • 5.6.1 REGULATORY LANDSCAPE
    • 5.6.1.1 North America
      • 5.6.1.1.1 US
      • 5.6.1.1.2 Canada
    • 5.6.1.2 Europe
    • 5.6.1.3 Asia Pacific
      • 5.6.1.3.1 Japan
      • 5.6.1.3.2 China
      • 5.6.1.3.3 India
    • 5.6.1.4 Latin America
      • 5.6.1.4.1 Brazil
  • 5.6.2 REGULATORY APPROVALS
  • 5.6.3 KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• 5.7 REIMBURSEMENT SCENARIO ANALYSIS
• 5.8 INVESTMENT AND FUNDING SCENARIO
• 5.9 PRICING ANALYSIS
  • 5.9.1 AVERAGE SELLING PRICE OF KEY PLAYERS, BY TECHNOLOGY
  • 5.9.2 AVERAGE SELLING PRICE OF BODY CONTOURING DEVICES, BY REGION
• 5.10 TRADE ANALYSIS
  • 5.10.1 IMPORT DATA
  • 5.10.2 EXPORT DATA
• 5.11 PATENT ANALYSIS
• 5.12 PORTER'S FIVE FORCES ANALYSIS
  • 5.12.1 THREAT OF NEW ENTRANTS
  • 5.12.2 THREAT OF SUBSTITUTES
  • 5.12.3 BARGAINING POWER OF SUPPLIERS
  • 5.12.4 BARGAINING POWER OF BUYERS
  • 5.12.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.13.2 KEY BUYING CRITERIA
• 5.14 KEY CONFERENCES AND EVENTS, 2025-2026
• 5.15 CASE STUDY ANALYSIS
  • 5.15.1 IMPROVED FAT REDUCTION PROCEDURES USING LARGER APPLICATOR
  • 5.15.2 ENHANCED SUPPLY CHAIN AND OPERATIONAL EFFICIENCY WITH HIGHER RESEARCH & DEVELOPMENT
• 5.16 TECHNOLOGY ANALYSIS
  • 5.16.1 KEY TECHNOLOGIES
    • 5.16.1.1 Thermal technologies
    • 5.16.1.2 Non-thermal technologies
  • 5.16.2 COMPLEMENTARY TECHNOLOGIES
    • 5.16.2.1 Skin cooling systems
  • 5.16.3 ADJACENT TECHNOLOGIES
    • 5.16.3.1 Treatment planning software
• 5.17 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
• 5.18 UNMET NEEDS
• 5.19 IMPACT OF AI/GEN AI ON BODY CONTOURING TREATMENTS MARKET
  • 5.19.1 KEY USE CASES

6 BODY CONTOURING TREATMENTS MARKET, BY TECHNOLOGY

• 6.1 INTRODUCTION
• 6.2 INVASIVE TECHNOLOGIES
  • 6.2.1 INVASIVE RADIOFREQUENCY TECHNOLOGY
    • 6.2.1.1 Growing inclination toward skin tightening to propel market
  • 6.2.2 INVASIVE LASER TECHNOLOGY
    • 6.2.2.1 Higher advantages compared to traditional techniques to speed up growth
  • 6.2.3 INVASIVE ULTRASOUND TECHNOLOGY
    • 6.2.3.1 Targeted fat reduction and minimal discomfort to augment growth
• 6.3 NON-INVASIVE TECHNOLOGIES
  • 6.3.1 NON-INVASIVE RADIOFREQUENCY TECHNOLOGY
    • 6.3.1.1 Rising use of cellulite treatment, fat reduction, and skin tightening to drive market
  • 6.3.2 NON-INVASIVE LASER TECHNOLOGY
    • 6.3.2.1 Growing adoption in hospitals and aesthetic clinics to fuel market
  • 6.3.3 NON-INVASIVE ULTRASOUND TECHNOLOGY
    • 6.3.3.1 Need for precise temperature management control to accelerate growth
  • 6.3.4 CRYOLIPOLYSIS TECHNOLOGY
    • 6.3.4.1 Low risk and minimal side effects to facilitate growth
  • 6.3.5 OTHER NON-INVASIVE TECHNOLOGIES

7 BODY CONTOURING TREATMENTS MARKET, BY GENDER

• 7.1 INTRODUCTION
• 7.2 FEMALE PATIENTS
  • 7.2.1 GROWING USE OF BODY CONTOURING TO ADDRESS POST-SURGICAL CHANGES TO BOOST MARKET
• 7.3 MALE PATIENTS
  • 7.3.1 INCREASING SHIFT IN SOCIAL AND AESTHETIC STANDARDS TO EXPEDITE GROWTH

8 BODY CONTOURING TREATMENTS MARKET, BY APPLICATION

• 8.1 INTRODUCTION
• 8.2 NON-SURGICAL FAT REDUCTION
  • 8.2.1 GROWING PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES TO FUEL MARKET
• 8.3 CELLULITE REDUCTION
  • 8.3.1 RISING OBESITY RATES TO SUPPORT MARKET GROWTH
• 8.4 LIPOSUCTION
  • 8.4.1 GROWING DEMAND FOR COSMETIC ENHANCEMENT WITH SHORTER RECOVERY TIMES TO DRIVE MARKET
• 8.5 ABDOMINOPLASTY
  • 8.5.1 INCREASING DESIRE FOR AESTHETIC IMPROVEMENTS TO PROMOTE GROWTH
• 8.6 OTHER APPLICATIONS

9 BODY CONTOURING TREATMENTS MARKET, BY END USER

• 9.1 INTRODUCTION
• 9.2 HOSPITALS
  • 9.2.1 BOOMING MEDICAL TOURISM TO CONTRIBUTE TO MARKET GROWTH
• 9.3 AESTHETIC CLINICS
  • 9.3.1 GROWING ESTABLISHMENT OF SPECIALTY CLINICS TO DRIVE MARKET
• 9.4 MEDICAL SPAS & BEAUTY CENTERS
  • 9.4.1 RISING FOCUS ON BODY APPEARANCE TO AID GROWTH

10 BODY CONTOURING TREATMENTS MARKET, BY REGION

• 10.1 INTRODUCTION
• 10.2 NORTH AMERICA
  • 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 10.2.2 US
    • 10.2.2.1 Growing public acceptance of body contouring procedures to drive market
  • 10.2.3 CANADA
    • 10.2.3.1 Rising inclination toward reducing signs of aging to aid growth
• 10.3 EUROPE
  • 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 10.3.2 GERMANY
    • 10.3.2.1 Increasing volume of aesthetic procedures to drive market
  • 10.3.3 FRANCE
    • 10.3.3.1 Increasing demand for age-related aesthetic treatments to spur growth
  • 10.3.4 UK
    • 10.3.4.1 Rising focus of men on body aesthetics to encourage growth
  • 10.3.5 ITALY
    • 10.3.5.1 Gowing adoption of surgical procedures among young females to boost market
  • 10.3.6 SPAIN
    • 10.3.6.1 Growing availability of high-quality and effective products to fuel market
  • 10.3.7 REST OF EUROPE
• 10.4 ASIA PACIFIC
  • 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 10.4.2 JAPAN
    • 10.4.2.1 Presence of medical aesthetic associations to spur growth
  • 10.4.3 CHINA
    • 10.4.3.1 Increased availability of cosmetic surgery apps and online services to support growth
  • 10.4.4 INDIA
    • 10.4.4.1 Increasing disposable income to contribute to market growth
  • 10.4.5 AUSTRALIA
    • 10.4.5.1 Favorable government initiatives to promote growth
  • 10.4.6 SOUTH KOREA
    • 10.4.6.1 Rising influx of foreign patients to facilitate growth
  • 10.4.7 REST OF ASIA PACIFIC
• 10.5 LATIN AMERICA
  • 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 10.5.2 BRAZIL
    • 10.5.2.1 Heightened awareness regarding body contouring enhancements to stimulate growth
  • 10.5.3 MEXICO
    • 10.5.3.1 Increase in patient inflow from US to sustain growth
  • 10.5.4 REST OF LATIN AMERICA
• 10.6 MIDDLE EAST & AFRICA
  • 10.6.1 GROWING AVAILABILITY OF HIGH-QUALITY TREATMENTS TO DRIVE MARKET
  • 10.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE

• 11.1 OVERVIEW
• 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN BODY CONTOURING TREATMENTS MARKET
• 11.3 REVENUE ANALYSIS, 2019-2023
• 11.4 MARKET SHARE ANALYSIS, 2023
• 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 11.5.1 STARS
  • 11.5.2 EMERGING LEADERS
  • 11.5.3 PERVASIVE PLAYERS
  • 11.5.4 PARTICIPANTS
  • 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 11.5.5.1 Company footprint
    • 11.5.5.2 Technology footprint
    • 11.5.5.3 Gender footprint
    • 11.5.5.4 Application footprint
    • 11.5.5.5 End-user footprint
    • 11.5.5.6 Region footprint
• 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
  • 11.6.1 PROGRESSIVE COMPANIES
  • 11.6.2 RESPONSIVE COMPANIES
  • 11.6.3 DYNAMIC COMPANIES
  • 11.6.4 STARTING BLOCKS
  • 11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
• 11.7 COMPANY VALUATION AND FINANCIAL METRICS
  • 11.7.1 COMPANY VALUATION
  • 11.7.2 FINANCIAL METRICS
• 11.8 BRAND/PRODUCT COMPARISON
• 11.9 COMPETITIVE SCENARIO
  • 11.9.1 PRODUCT LAUNCHES AND APPROVALS
  • 11.9.2 DEALS
  • 11.9.3 EXPANSIONS

12 COMPANY PROFILES

• 12.1 KEY PLAYERS
  • 12.1.1 ABBVIE INC.
    • 12.1.1.1 Business overview
    • 12.1.1.2 Products offered
    • 12.1.1.3 Recent developments
      • 12.1.1.3.1 Product launches and approvals
    • 12.1.1.4 MnM view
      • 12.1.1.4.1 Key strengths
      • 12.1.1.4.2 Strategic choices
      • 12.1.1.4.3 Weaknesses and competitive threats
  • 12.1.2 INMODE LTD.
    • 12.1.2.1 Business overview
    • 12.1.2.2 Products offered
    • 12.1.2.3 Recent developments
      • 12.1.2.3.1 Product launches and approvals
      • 12.1.2.3.2 Deals
    • 12.1.2.4 MnM view
      • 12.1.2.4.1 Key strengths
      • 12.1.2.4.2 Strategic choices
      • 12.1.2.4.3 Weaknesses and competitive threats
  • 12.1.3 BAUSCH HEALTH COMPANIES INC.
    • 12.1.3.1 Business overview
    • 12.1.3.2 Products offered
    • 12.1.3.3 Recent developments
      • 12.1.3.3.1 Product launches and approvals
    • 12.1.3.4 MnM view
      • 12.1.3.4.1 Key strengths
      • 12.1.3.4.2 Strategic choices
      • 12.1.3.4.3 Weaknesses and competitive threats
  • 12.1.4 CYNOSURE LUTRONIC
    • 12.1.4.1 Business overview
    • 12.1.4.2 Products offered
    • 12.1.4.3 Recent developments
      • 12.1.4.3.1 Deals
    • 12.1.4.4 MnM view
      • 12.1.4.4.1 Key strengths
      • 12.1.4.4.2 Strategic choices
      • 12.1.4.4.3 Weaknesses and competitive threats
  • 12.1.5 SISRAM MEDICAL LTD
    • 12.1.5.1 Business overview
    • 12.1.5.2 Products offered
    • 12.1.5.3 Recent developments
      • 12.1.5.3.1 Product launches and approvals
      • 12.1.5.3.2 Deals
      • 12.1.5.3.3 Expansions
    • 12.1.5.4 MnM view
      • 12.1.5.4.1 Key strengths
      • 12.1.5.4.2 Strategic choices
      • 12.1.5.4.3 Weaknesses and competitive threats
  • 12.1.6 CUTERA, INC.
    • 12.1.6.1 Business overview
    • 12.1.6.2 Products offered
    • 12.1.6.3 Recent developments
      • 12.1.6.3.1 Product launches and approvals
  • 12.1.7 EL.EN. S.P.A.
    • 12.1.7.1 Business overview
    • 12.1.7.2 Products offered
      • 12.1.7.2.1 Product launches and approvals
  • 12.1.8 VENUS CONCEPT
    • 12.1.8.1 Business overview
    • 12.1.8.2 Products offered
    • 12.1.8.3 Recent developments
      • 12.1.8.3.1 Product launches and approvals
      • 12.1.8.3.2 Deals
  • 12.1.9 SHARPLIGHT TECHNOLOGIES INC.
    • 12.1.9.1 Business overview
    • 12.1.9.2 Products offered
    • 12.1.9.3 Recent developments
      • 12.1.9.3.1 Product launches and approvals
  • 12.1.10 SCITON
    • 12.1.10.1 Business overview
    • 12.1.10.2 Products offered
    • 12.1.10.3 Recent developments
      • 12.1.10.3.1 Product launches and approvals
  • 12.1.11 CANDELA CORPORATION
    • 12.1.11.1 Business overview
    • 12.1.11.2 Products offered
    • 12.1.11.3 Recent developments
      • 12.1.11.3.1 Deals
  • 12.1.12 BTL INDUSTRIES
    • 12.1.12.1 Business overview
    • 12.1.12.2 Products offered
    • 12.1.12.3 Recent developments
      • 12.1.12.3.1 Product launches and approvals
      • 12.1.12.3.2 Deals
  • 12.1.13 FOTONA
    • 12.1.13.1 Business overview
    • 12.1.13.2 Products offered
    • 12.1.13.3 Recent developments
      • 12.1.13.3.1 Product launches and approvals
  • 12.1.14 GZ MTS ELECTRONICS CO., LTD.
    • 12.1.14.1 Business overview
    • 12.1.14.2 Products offered
  • 12.1.15 ROHRER AESTHETICS, INC.
    • 12.1.15.1 Business overview
    • 12.1.15.2 Products offered
    • 12.1.15.3 Recent developments
      • 12.1.15.3.1 Product launches and approvals
      • 12.1.15.3.2 Deals
• 12.2 OTHER PLAYERS
  • 12.2.1 GBS INTERNATIONAL HOLDING LTD.
  • 12.2.2 SINCLAIR
  • 12.2.3 THERMI
  • 12.2.4 YOLO MEDICAL INC.
  • 12.2.5 DOMINION AESTHETIC TECHNOLOGIES, INC.
  • 12.2.6 ZIMMER MEDIZIN SYSTEME GMBH
  • 12.2.7 ERCHONIA CORPORATION
  • 12.2.8 CLASSYS INC.
  • 12.2.9 WON TECH CO., LTD.
  • 12.2.10 CELLSOUND AESTHETICS

13 APPENDIX

• 13.1 DISCUSSION GUIDE
• 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 13.3 CUSTOMIZATION OPTIONS
• 13.4 RELATED REPORTS
• 13.5 AUTHOR DETAILS